VI.4 Identification of tamoxifen-DNA adducts

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Martin, E A ^a   White, I N H ^a   Turteltau, K W ^b   Smith, L L ^a  

^a MRC TOXICOLOGY UNIT   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TAMOXIFEN;

CONFERENCE PAPER; DNA ADDUCT; DRUG DNA BINDING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROXYLATION; LIVER; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY;

EID: 0031667723     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00122-1     Document Type: Conference Paper

References (5)

1. 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation. Carcinogenesis 1995, 16, 1299-1304.
2. 32P-postlabelled DNA adducts in liver from women treated with tamoxifen. Carcinogenesis 1995, 16, 1651-1654.
3. Osborne MR, Hardcastle IR, Phillips DH. Minor products of reaction of DNA with α-acetoxytamoxifen. Carcinogenesis 1997, 18, 539-543.
4. Carthew P, Edwards RE, Nolan BM, Martin EA, Smith LL. Tamoxifen associated uterine pathology in rodents: relevance to women. Carcinogenesis 1996, 17, 1577-1582.
5. Vogel JS, Turteltaub KW. Accelerator mass spectrometry in biomedical research. Nucl Inst Meth Physics Res 1994, 94, 445-453.